Simon Nyarko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Simon Nyarko has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Julius Caesar Mahama
University Hospitals of Morecambe Bay NHS Foundation Trust, Furness General Hospital , Dalton Lane LA14 4LF
4 shared publications- Roger Ayimbillah Atinga
University of Ghana Business School, Legon, Accra, Ghana
3 shared publications Denis Dekugmen Yar
Department of Public Health, Akenten Appiah-Menka University of Skills Training and Entrepreneurial Development, Mampong, Ghana
2 shared publications- Dennis Bardoe
Department of Public health Education, Akenten Appiah-Menka University of Skills Training and Entrepreneurial Development, Mampong, Ghana
2 shared publications - Kwabena Ofori-Kwakye
Department of Pharmaceutics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
2 shared publications Noble Kuntworbe
Department of Pharmaceutics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
2 shared publications
Latest Publications
- Open Access
- 22 August 2026
- Published by Springer Nature in Discover Mental Health
- Vol. 6 (1)
Psychometric analysis of brief adolescent gambling screen, problem gambling severity index, and gambling motives questionnaire-financial among Ghanaian adolescents
- 22 August 2026
- Published by Springer Nature in Discover Mental Health
- Vol. 6 (1)
Open AccessPsychometric analysis of brief adolescent gambling screen, problem gambling severity index, and gambling motives questionnaire-financial among Ghanaian adolescents
- Open Access
- 17 June 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Drivers of trimester disparities in asymptomatic malaria during pregnancy in Kintampo South District: evidence from an Oaxaca-Blinder decomposition Analysis
Asymptomatic malaria in pregnancy (AMiP) remains a major public health challenge with important maternal and neonatal consequences. Despite ongoing malaria control efforts, little is known about trimester-specific disparities in AMiP and the extent to which these differences are explained by socioeconomic, clinical, and environmental factors. Most existing studies have focused on overall malaria burden rather than explaining disparities across gestation. This study examined the determinants of trimester disparities in AMiP in the Kintampo South District of Ghana using Oaxaca-Blinder decomposition. A facility-based cross-sectional study was conducted among 462 pregnant women in the Kintampo South District of Ghana. Peripheral blood samples were screened for Plasmodium species using microscopy, while structured questionnaires captured sociodemographic, clinical, and environmental characteristics. Data were analysed with STATA 17 using Oaxaca-Blinder decomposition to partition trimester differences in AMiP into explained(characteristics) and unexplained (coefficients) components. The overall prevalence of AMiP was 13.4%, with a significantly higher burden in the second trimester (χ2 = 10.96, p < 0.001). Plasmodium falciparum accounted for most infections. Oaxaca-Blinder decomposition showed that 73.7% of the trimester disparity in AMiP was explained by differences in observed characteristics (endowments). The major contributors to the explained disparity were suboptimal uptake of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) (71.3%), frequent evening outdoor activity (58.6%), infrequent use of mosquito repellents (50.6%), proximity to overgrown vegetation (42.5%), ≤2 malaria diagnostic tests during antenatal care (ANC) (24.1%), and infrequent iron-folate supplementation (18.4%). Conversely, ownership of long-lasting insecticidal nets (LLINs) reduced the unexplained disparity by 41.9%, highlighting its protective effect. Disparities in AMiP across trimesters are primarily driven by modifiable socioeconomic, programmatic, and environmental factors rather than inherent biological differences in gestation. These highlight the need to strengthen the prioritisation of early initiation of ANC and frequent exposure to provider-supervised IPTp-SP uptake. In addition, promoting sustained use of LLINs and repellents, alongside community-level environmental management, is critical to reducing exposure risk. Finally, embedding these targeted interventions within ANC services, supported by coordinated multisectoral efforts, will be essential to reduce trimester-specific inequities and improve maternal health outcomes.
- 17 June 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessDrivers of trimester disparities in asymptomatic malaria during pregnancy in Kintampo South District: evidence from an Oaxaca-Blinder decomposition Analysis
Asymptomatic malaria in pregnancy (AMiP) remains a major public health challenge with important maternal and neonatal consequences. Despite ongoing malaria control efforts, little is known about trimester-specific disparities in AMiP and the extent to which these differences are explained by socioeconomic, clinical, and environmental factors. Most existing studies have focused on overall malaria burden rather than explaining disparities across gestation. This study examined the determinants of trimester disparities in AMiP in the Kintampo South District of Ghana using Oaxaca-Blinder decomposition. A facility-based cross-sectional study was conducted among 462 pregnant women in the Kintampo South District of Ghana. Peripheral blood samples were screened for Plasmodium species using microscopy, while structured questionnaires captured sociodemographic, clinical, and environmental characteristics. Data were analysed with STATA 17 using Oaxaca-Blinder decomposition to partition trimester differences in AMiP into explained(characteristics) and unexplained (coefficients) components. The overall prevalence of AMiP was 13.4%, with a significantly higher burden in the second trimester (χ2 = 10.96, p < 0.001). Plasmodium falciparum accounted for most infections. Oaxaca-Blinder decomposition showed that 73.7% of the trimester disparity in AMiP was explained by differences in observed characteristics (endowments). The major contributors to the explained disparity were suboptimal uptake of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) (71.3%), frequent evening outdoor activity (58.6%), infrequent use of mosquito repellents (50.6%), proximity to overgrown vegetation (42.5%), ≤2 malaria diagnostic tests during antenatal care (ANC) (24.1%), and infrequent iron-folate supplementation (18.4%). Conversely, ownership of long-lasting insecticidal nets (LLINs) reduced the unexplained disparity by 41.9%, highlighting its protective effect. Disparities in AMiP across trimesters are primarily driven by modifiable socioeconomic, programmatic, and environmental factors rather than inherent biological differences in gestation. These highlight the need to strengthen the prioritisation of early initiation of ANC and frequent exposure to provider-supervised IPTp-SP uptake. In addition, promoting sustained use of LLINs and repellents, alongside community-level environmental management, is critical to reducing exposure risk. Finally, embedding these targeted interventions within ANC services, supported by coordinated multisectoral efforts, will be essential to reduce trimester-specific inequities and improve maternal health outcomes.
- RetractedOpen Access
- 24 March 2026
- Published by SAGE Publications in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
- Vol. 63
Leveraging Artificial Intelligence for Substance Use Prevention Among Adolescents: A Systematic Review of Emerging Evidence
Artificial intelligence is increasingly explored as an alternative approach for adolescent substance use prevention, yet it remains unclear whether existing applications demonstrate sufficient maturity, effectiveness, or public health value. We conducted a systematic review to synthesise the emerging evidence on artificial intelligence–based approaches for adolescent substance use prevention. We conducted a systematic review in line with PRISMA 2020 and SWiM guidance. We searched PubMed, Scopus, Web of Science, PsycINFO, IEEE Xplore, African Journals Online, Google, and Google Scholar from inception to August 2025. We included empirical studies that examined artificial intelligence-based approaches for adolescent substance use prevention, including risk identification and prevention-relevant engagement, among individuals aged 10 to 19 years. We extracted data on application functions, stage of development, reported outcomes, and ethical considerations. Given the diversity of study designs and outcome measures, we synthesised findings narratively. Prediction-modelling studies were assessed using PROBAST + AI. The review protocol was registered with PROSPERO (CRD420251105170). Ten studies met the inclusion criteria, spanning low-, middle-, and high-income settings. Most applications focussed on predictive modelling to identify substance use risk, while fewer evaluated user-facing conversational agents or chatbots. Across studies, systems largely remained at proof-of-concept or pilot stages. Outcome reporting was dominated by technical performance measures, feasibility assessments, and short-term engagement indicators; no study evaluated behavioural prevention outcomes, such as delayed initiation or reductions in substance use. Ethical considerations, including privacy, consent, stigma, bias, and accountability, were frequently identifiable but addressed inconsistently. Current evidence suggests that artificial intelligence in adolescent substance use prevention remains largely confined to technical feasibility, with no demonstrated effects on behavioural prevention outcomes. Future research should prioritise rigorous evaluation of prevention-relevant outcomes, embed ethics-by-design, and situate artificial intelligence applications within established prevention systems.
- 24 March 2026
- Published by SAGE Publications in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
- Vol. 63
RetractedOpen AccessLeveraging Artificial Intelligence for Substance Use Prevention Among Adolescents: A Systematic Review of Emerging Evidence
Artificial intelligence is increasingly explored as an alternative approach for adolescent substance use prevention, yet it remains unclear whether existing applications demonstrate sufficient maturity, effectiveness, or public health value. We conducted a systematic review to synthesise the emerging evidence on artificial intelligence–based approaches for adolescent substance use prevention. We conducted a systematic review in line with PRISMA 2020 and SWiM guidance. We searched PubMed, Scopus, Web of Science, PsycINFO, IEEE Xplore, African Journals Online, Google, and Google Scholar from inception to August 2025. We included empirical studies that examined artificial intelligence-based approaches for adolescent substance use prevention, including risk identification and prevention-relevant engagement, among individuals aged 10 to 19 years. We extracted data on application functions, stage of development, reported outcomes, and ethical considerations. Given the diversity of study designs and outcome measures, we synthesised findings narratively. Prediction-modelling studies were assessed using PROBAST + AI. The review protocol was registered with PROSPERO (CRD420251105170). Ten studies met the inclusion criteria, spanning low-, middle-, and high-income settings. Most applications focussed on predictive modelling to identify substance use risk, while fewer evaluated user-facing conversational agents or chatbots. Across studies, systems largely remained at proof-of-concept or pilot stages. Outcome reporting was dominated by technical performance measures, feasibility assessments, and short-term engagement indicators; no study evaluated behavioural prevention outcomes, such as delayed initiation or reductions in substance use. Ethical considerations, including privacy, consent, stigma, bias, and accountability, were frequently identifiable but addressed inconsistently. Current evidence suggests that artificial intelligence in adolescent substance use prevention remains largely confined to technical feasibility, with no demonstrated effects on behavioural prevention outcomes. Future research should prioritise rigorous evaluation of prevention-relevant outcomes, embed ethics-by-design, and situate artificial intelligence applications within established prevention systems.
- Open Access
- 16 March 2026
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 41 (5) , 898-912
Pain, policy, and the opioid dilemma in sub-Saharan Africa: a systematic review of access, regulation, and health governance from 1990 to 2024
Sub-Saharan Africa (SSA) faces a dual opioid dilemma: widespread undertreatment of moderate to severe pain due to limited access to essential opioid analgesics, alongside increasing concern about misuse and diversion in selected contexts. Opioids are clinically indicated for severe cancer-related pain, advanced chronic illness, major trauma, surgery, and end-of-life care; yet, regional consumption remains disproportionately low relative to documented disease burden, indicating systemic under-provision rather than low need. This systematic review synthesizes evidence on opioid policy, regulation, access, and governance in SSA to examine how legal frameworks, institutional arrangements, political dynamics, and data systems shape medical availability. Following PRISMA and SWiM guidance, we reviewed peer-reviewed and gray literature addressing national drug control laws, regulatory implementation, procurement and supply systems, prescribing authority, and surveillance capacity; 33 studies met inclusion criteria. Across settings, restrictive or ambiguously interpreted legislation, multi-layered administrative controls, fragmented mandates across health and enforcement institutions, weak forecasting and distribution systems, concentrated prescribing authority, professional risk aversion, and chronic data gaps were consistently associated with constrained access. Concurrently, rising political and media attention to non-medical use, particularly of tramadol, has reinforced enforcement-oriented narratives that may further limit reform space. Persistent deficiencies in routine consumption data and unmet need assessment contribute to conservative import quotas and regulatory inertia. Addressing this imbalance requires proportionate, sequenced reform that strengthens data and forecasting systems, clarifies and aligns legal mandates with public health objectives, invests in workforce capacity and supply chains, and embeds safeguards against diversion while correcting avoidable under-treatment.
- 16 March 2026
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 41 (5) , 898-912
Open AccessPain, policy, and the opioid dilemma in sub-Saharan Africa: a systematic review of access, regulation, and health governance from 1990 to 2024
Sub-Saharan Africa (SSA) faces a dual opioid dilemma: widespread undertreatment of moderate to severe pain due to limited access to essential opioid analgesics, alongside increasing concern about misuse and diversion in selected contexts. Opioids are clinically indicated for severe cancer-related pain, advanced chronic illness, major trauma, surgery, and end-of-life care; yet, regional consumption remains disproportionately low relative to documented disease burden, indicating systemic under-provision rather than low need. This systematic review synthesizes evidence on opioid policy, regulation, access, and governance in SSA to examine how legal frameworks, institutional arrangements, political dynamics, and data systems shape medical availability. Following PRISMA and SWiM guidance, we reviewed peer-reviewed and gray literature addressing national drug control laws, regulatory implementation, procurement and supply systems, prescribing authority, and surveillance capacity; 33 studies met inclusion criteria. Across settings, restrictive or ambiguously interpreted legislation, multi-layered administrative controls, fragmented mandates across health and enforcement institutions, weak forecasting and distribution systems, concentrated prescribing authority, professional risk aversion, and chronic data gaps were consistently associated with constrained access. Concurrently, rising political and media attention to non-medical use, particularly of tramadol, has reinforced enforcement-oriented narratives that may further limit reform space. Persistent deficiencies in routine consumption data and unmet need assessment contribute to conservative import quotas and regulatory inertia. Addressing this imbalance requires proportionate, sequenced reform that strengthens data and forecasting systems, clarifies and aligns legal mandates with public health objectives, invests in workforce capacity and supply chains, and embeds safeguards against diversion while correcting avoidable under-treatment.
- Top Cited PapersOpen Access
- 9 March 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Digital health system integration in Ghana: a scoping review of governance arrangements, interoperability aspirations, and regulatory gaps
Digital health systems are increasingly central to health system performance, yet many low- and middle-income countries continue to struggle with integrati
- 9 March 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Top Cited PapersOpen AccessDigital health system integration in Ghana: a scoping review of governance arrangements, interoperability aspirations, and regulatory gaps
Digital health systems are increasingly central to health system performance, yet many low- and middle-income countries continue to struggle with integrati
- Top Cited Papers
- 15 January 2026
- Published by SAGE Publications in The Journal of Environment & Development
- Vol. 35 (2) , 547-572
Circular Economy—Sustainable City Nexus: The Place of Circular Economy in Advancing Sustainable Ghanaian Cities
This systematic review examines the role of the circular economy (CE) in promoting sustainable urban development in Ghanaian cities. Using a Boolean search, 20 peer-reviewed articles, reports, and policy documents were analyzed from Scopus, ScienceDirect, DOAJ, AJOL, and Google Scholar. Grounded in the sustainable city nexus, the review identifies resource efficiency and waste management, renewable energy integration, sustainable urban planning and design, community engagement and education, and green and blue infrastructure as key characteristics of CE in Ghanaian cities. Despite progress, challenges persist, including inadequate infrastructure, low recycling rates, limited public awareness, fragmented governance, and poorly managed end-of-life waste. The review advances a holistic understanding of CE, proposes a framework for policymakers, and highlights opportunities for cross-sector collaboration and context-driven interventions.
- 15 January 2026
- Published by SAGE Publications in The Journal of Environment & Development
- Vol. 35 (2) , 547-572
Top Cited PapersCircular Economy—Sustainable City Nexus: The Place of Circular Economy in Advancing Sustainable Ghanaian Cities
This systematic review examines the role of the circular economy (CE) in promoting sustainable urban development in Ghanaian cities. Using a Boolean search, 20 peer-reviewed articles, reports, and policy documents were analyzed from Scopus, ScienceDirect, DOAJ, AJOL, and Google Scholar. Grounded in the sustainable city nexus, the review identifies resource efficiency and waste management, renewable energy integration, sustainable urban planning and design, community engagement and education, and green and blue infrastructure as key characteristics of CE in Ghanaian cities. Despite progress, challenges persist, including inadequate infrastructure, low recycling rates, limited public awareness, fragmented governance, and poorly managed end-of-life waste. The review advances a holistic understanding of CE, proposes a framework for policymakers, and highlights opportunities for cross-sector collaboration and context-driven interventions.
- Open Access
- 10 June 2025
- Published by Wiley
Pain Management and the Opioid Policy Landscape in Sub-Saharan Africa: A Systematic Review of Access, Regulation, and Health Governance from 1990 to 2024
Background: Sub-Saharan Africa (SSA) faces a dual challenge of limited access to essential opioids for pain relief and increasing concerns about misuse, diversion, and trafficking. Despite opioids being classified as essential medicines, access across the region remains constrained by restrictive laws, fragmented governance, limited provider training, and widespread stigma. While calls for more balanced opioid policies exist, systematic evidence on access and governance in SSA remains limited. This systematic review synthesises existing data to inform policy, practice, and research. Methods: The review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search of six electronic databases and relevant grey literature was conducted. Studies were included if they focused on any SSA country and examined opioid policy, access, regulation, or governance. Only English-language studies published between 1990 and 2024 were included. Two reviewers independently screened and assessed study quality. Thematic and content analysis were used for data synthesis. Results: Thirty-three studies met inclusion criteria, covering diverse SSA contexts. Five major themes were identified: policy and regulatory frameworks, barriers to access, governance and institutional roles, political influences, and data gaps. Across most settings, restrictive regulations, operational bottlenecks, weak health systems, stigma, and insufficient training impede opioid availability. Policies often emphasise control over care, contributing to widespread untreated pain. While some countries have implemented reforms and harm reduction strategies, coordination and surveillance remain limited. Conclusions: Expanding opioid access in SSA requires regulatory reform, decentralised prescribing, provider training, and investment in harm reduction and health infrastructure. A balanced, rights-based approach is needed to address both the undertreatment of pain and the risks of misuse. However, this review is limited by its reliance on studies published in English, resulting in a geographically skewed evidence base. This highlights the urgent need for more inclusive and representative research across diverse Sub-Saharan African contexts. Protocol Registration : The protocol was prospectively registered with PROSPERO (CRD42025637149).
- 10 June 2025
- Published by Wiley
Open AccessPain Management and the Opioid Policy Landscape in Sub-Saharan Africa: A Systematic Review of Access, Regulation, and Health Governance from 1990 to 2024
Background: Sub-Saharan Africa (SSA) faces a dual challenge of limited access to essential opioids for pain relief and increasing concerns about misuse, diversion, and trafficking. Despite opioids being classified as essential medicines, access across the region remains constrained by restrictive laws, fragmented governance, limited provider training, and widespread stigma. While calls for more balanced opioid policies exist, systematic evidence on access and governance in SSA remains limited. This systematic review synthesises existing data to inform policy, practice, and research. Methods: The review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search of six electronic databases and relevant grey literature was conducted. Studies were included if they focused on any SSA country and examined opioid policy, access, regulation, or governance. Only English-language studies published between 1990 and 2024 were included. Two reviewers independently screened and assessed study quality. Thematic and content analysis were used for data synthesis. Results: Thirty-three studies met inclusion criteria, covering diverse SSA contexts. Five major themes were identified: policy and regulatory frameworks, barriers to access, governance and institutional roles, political influences, and data gaps. Across most settings, restrictive regulations, operational bottlenecks, weak health systems, stigma, and insufficient training impede opioid availability. Policies often emphasise control over care, contributing to widespread untreated pain. While some countries have implemented reforms and harm reduction strategies, coordination and surveillance remain limited. Conclusions: Expanding opioid access in SSA requires regulatory reform, decentralised prescribing, provider training, and investment in harm reduction and health infrastructure. A balanced, rights-based approach is needed to address both the undertreatment of pain and the risks of misuse. However, this review is limited by its reliance on studies published in English, resulting in a geographically skewed evidence base. This highlights the urgent need for more inclusive and representative research across diverse Sub-Saharan African contexts. Protocol Registration : The protocol was prospectively registered with PROSPERO (CRD42025637149).
- Open Access
The Exodus of Healthcare Professionals from Ghana and its Effect on the Healthcare System
The migration of healthcare professionals from low- and middle-income countries (LMICs) to high-income countries (HICs), often termed as brain drain, remains a significant and widely debated issue. This study examines the exodus of healthcare workers from Ghana and its impact on the country's health system. Using a scoping review methodology, we mapped and synthesized existing literature on migration of healthcare professionals from Ghana, focusing on key challenges and strategies to address this phenomenon. The Population, Concept, Context (PCC) framework was systematically applied to define study eligibility criteria. The search strategy employed Boolean operators (AND/OR) with key MeSH words including healthcare workforce, health policy, migration, brain drain, intervention strategies, and Ghana across databases such as PubMed, Google Scholar, Scopus, and Web of Science. Eleven (11) studies met the inclusion criteria. The review identified low wages, poor working conditions, limited career advancement opportunities, and political instability as primary drivers of healthcare migration of healthcare professionals. To mitigate these challenges, efforts should focus on improving domestic conditions for healthcare workers, including enhanced remuneration, better service conditions, and career development initiatives. Additionally, governments must prioritize strengthening healthcare infrastructure, particularly in rural regions, to reduce disparities in service delivery. The findings also suggest that partnerships with high-income countries could facilitate skills development programs for Ghanaian healthcare workers, provided such collaborations include strengthened agreements (e.g., bonding schemes) to ensure professionals return to apply their expertise domestically. While the scoping review synthesizes critical insights, further empirical studies targeting specific regions or demographic blocs are needed to assess whether migration trends have persisted or evolved. Future research should also explore new subpopulations, geographic contexts, or timeframes to evaluate the reproducibility of existing findings and their applicability to contemporary or shifting socioeconomic landscapes.
Open AccessThe Exodus of Healthcare Professionals from Ghana and its Effect on the Healthcare System
The migration of healthcare professionals from low- and middle-income countries (LMICs) to high-income countries (HICs), often termed as brain drain, remains a significant and widely debated issue. This study examines the exodus of healthcare workers from Ghana and its impact on the country's health system. Using a scoping review methodology, we mapped and synthesized existing literature on migration of healthcare professionals from Ghana, focusing on key challenges and strategies to address this phenomenon. The Population, Concept, Context (PCC) framework was systematically applied to define study eligibility criteria. The search strategy employed Boolean operators (AND/OR) with key MeSH words including healthcare workforce, health policy, migration, brain drain, intervention strategies, and Ghana across databases such as PubMed, Google Scholar, Scopus, and Web of Science. Eleven (11) studies met the inclusion criteria. The review identified low wages, poor working conditions, limited career advancement opportunities, and political instability as primary drivers of healthcare migration of healthcare professionals. To mitigate these challenges, efforts should focus on improving domestic conditions for healthcare workers, including enhanced remuneration, better service conditions, and career development initiatives. Additionally, governments must prioritize strengthening healthcare infrastructure, particularly in rural regions, to reduce disparities in service delivery. The findings also suggest that partnerships with high-income countries could facilitate skills development programs for Ghanaian healthcare workers, provided such collaborations include strengthened agreements (e.g., bonding schemes) to ensure professionals return to apply their expertise domestically. While the scoping review synthesizes critical insights, further empirical studies targeting specific regions or demographic blocs are needed to assess whether migration trends have persisted or evolved. Future research should also explore new subpopulations, geographic contexts, or timeframes to evaluate the reproducibility of existing findings and their applicability to contemporary or shifting socioeconomic landscapes.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Parasitology Research
- Vol. 2025 (1) , 4079763
Efficacy of Anthelmintics Against Canine Hookworm Infections in the Bono East Region of Ghana
Hookworm infections present a major health risk to dogs, especially in areas characterized by warmer climates and poor sanitation. This cross‐sectional study was undertaken to determine the prevalence of hookworm infections and the efficacy of anthelmintic treatments in dogs from the Bono East Region of Ghana. Four hundred and ninety‐one (491) canine stool samples were examined using the McMaster technique to ascertain the prevalence of hookworms. Using in vivo and in vitro techniques, the efficacy of three anthelmintics (albendazole, pyrantel, and niclosamide) was assessed in an experimental control trial involving dogs naturally infected with hookworms. The effects of the drugs on hematological and biochemical parameters were measured within a 14‐day period to assess changes over time. The study found a total prevalence of 54.2% (266), with significantly higher infection rates in puppies (69.8%, 97), hunting dogs (64.1%, 91), and rural dogs (84.2%, 160). Logistic regression identified age, purpose, and settlement type as risk factors for infection. Of the three treatments, niclosamide was the most efficacious, reducing egg counts by 95%, while albendazole was the least efficacious (−69%). In vitro tests confirmed the superior performance of niclosamide, with the lowest IC 50 value of 29.19 μ g/mL. Hookworm‐infected dogs exhibited anemia, eosinophilia, hypoalbuminemia, and hypoproteinemia. There was significant improvement in the hematobiochemical parameters after treatment, particularly in niclosamide‐treated dogs. Veterinarians can consider niclosamide, especially in resource‐limited settings, due to its affordability. The findings emphasize the importance of regular monitoring and treatment of hookworm infections to improve the overall health and well‐being of dogs in the region. Herein, we report for the first time on reduced efficacy of albendazole and pyrantel against dog‐related hookworms in Ghana.
- 1 January 2025
- Published by Wiley in Journal of Parasitology Research
- Vol. 2025 (1) , 4079763
Open AccessEfficacy of Anthelmintics Against Canine Hookworm Infections in the Bono East Region of Ghana
Hookworm infections present a major health risk to dogs, especially in areas characterized by warmer climates and poor sanitation. This cross‐sectional study was undertaken to determine the prevalence of hookworm infections and the efficacy of anthelmintic treatments in dogs from the Bono East Region of Ghana. Four hundred and ninety‐one (491) canine stool samples were examined using the McMaster technique to ascertain the prevalence of hookworms. Using in vivo and in vitro techniques, the efficacy of three anthelmintics (albendazole, pyrantel, and niclosamide) was assessed in an experimental control trial involving dogs naturally infected with hookworms. The effects of the drugs on hematological and biochemical parameters were measured within a 14‐day period to assess changes over time. The study found a total prevalence of 54.2% (266), with significantly higher infection rates in puppies (69.8%, 97), hunting dogs (64.1%, 91), and rural dogs (84.2%, 160). Logistic regression identified age, purpose, and settlement type as risk factors for infection. Of the three treatments, niclosamide was the most efficacious, reducing egg counts by 95%, while albendazole was the least efficacious (−69%). In vitro tests confirmed the superior performance of niclosamide, with the lowest IC 50 value of 29.19 μ g/mL. Hookworm‐infected dogs exhibited anemia, eosinophilia, hypoalbuminemia, and hypoproteinemia. There was significant improvement in the hematobiochemical parameters after treatment, particularly in niclosamide‐treated dogs. Veterinarians can consider niclosamide, especially in resource‐limited settings, due to its affordability. The findings emphasize the importance of regular monitoring and treatment of hookworm infections to improve the overall health and well‐being of dogs in the region. Herein, we report for the first time on reduced efficacy of albendazole and pyrantel against dog‐related hookworms in Ghana.
- Open Access
- 13 July 2024
- Published by Sciencedomain International in Journal of Advances in Medical and Pharmaceutical Sciences
- Vol. 26 (7) , 1-20
In-Process Quality Checks and Post-Market Surveillance of Artemether-Lumefantrine Fixed-dose Combination Tablets and Suspensions: Current Procedures, Successes, Advances, and Challenges
In Southeast Asia and Sub-Saharan Africa, approximately 35% of antimalarial drugs are of substandard quality. Counterfeit and substandard medications constitute 10% of the global pharmaceutical trade. The World Health Organization (WHO) recommends artemether-lumefantrine (AL) as the first-line treatment for acute falciparum malaria in endemic regions. However, there is a lack of validated analytical methods to simultaneously determine the content of artemether and lumefantrine in these formulations, particularly in resource-limited settings. This paper focuses on quality concepts related to AL tablets and suspensions. It provides an overview of quality assessment techniques, including visual inspection, weight uniformity, content assay, and dissolution tests. Regulatory requirements and case studies are also discussed. By rigorously assessing AL quality, regulatory agencies, pharmaceutical companies, and healthcare professionals can ensure compliance with established standards and regulations.
- 13 July 2024
- Published by Sciencedomain International in Journal of Advances in Medical and Pharmaceutical Sciences
- Vol. 26 (7) , 1-20
Open AccessIn-Process Quality Checks and Post-Market Surveillance of Artemether-Lumefantrine Fixed-dose Combination Tablets and Suspensions: Current Procedures, Successes, Advances, and Challenges
In Southeast Asia and Sub-Saharan Africa, approximately 35% of antimalarial drugs are of substandard quality. Counterfeit and substandard medications constitute 10% of the global pharmaceutical trade. The World Health Organization (WHO) recommends artemether-lumefantrine (AL) as the first-line treatment for acute falciparum malaria in endemic regions. However, there is a lack of validated analytical methods to simultaneously determine the content of artemether and lumefantrine in these formulations, particularly in resource-limited settings. This paper focuses on quality concepts related to AL tablets and suspensions. It provides an overview of quality assessment techniques, including visual inspection, weight uniformity, content assay, and dissolution tests. Regulatory requirements and case studies are also discussed. By rigorously assessing AL quality, regulatory agencies, pharmaceutical companies, and healthcare professionals can ensure compliance with established standards and regulations.